Neurological comorbidity in children with neurofibromatosis type 1

作者：Hirabaru Keiko; Matsuo Muneaki^*

来源：Pediatrics International, 2018, 60(1): 70-75.

DOI：10.1111/ped.13388

• attention deficit-hyperactivity disorder
• autism
• comorbidity
• migraine
• neurofibromatosis type 1

BackgroundThe aim of this study was to determine the frequency of central nervous system comorbidities in children with neurofibromatosis type 1 (NF1).
MethodsWe performed a nationwide survey to investigate neurological comorbidities in 3-15-year-old children with NF1 in Japan by sending questionnaires to pediatricians and pediatric neurologists. A secondary questionnaire was sent to the parents of identified NF1 patients to assess neurological comorbidities including headache, attention deficit-hyperactivity disorder (ADHD) Rating Scale (RS), and the Social Responsiveness Scale 2.
ResultsThe primary survey identified 760 NF1 patients, and the parents of 565 patients were sent the secondary questionnaire. The parental response rate was 25.7% (145; 63 girls, 81 boys, one unspecified). Among the patients, 42.9% (55/128; 35 girls, 20 boys) were reported to exhibit intellectual problems. On the ADHD-RS, 40.2% (47/117) of NF1 patients aged 6-15 had ADHD (RS score >93rd percentile), with a rate of 47.7% in boys and 30.8% in girls. Furthermore, 20.2% of patients had suspected autism spectrum disorder (29/143; 10 girls, 19 boys), with Social Responsiveness Scale score 76. Headache was reported by 49.6% (61/123) of children over 5 years old, and 25.2% (31/123; 10 girls, 21 boys) reported migraine. Other neurological comorbidities included 20 cases of epilepsy (13.8%), 11 cases of optic nerve glioma (7.6%), five cases of brain tumor (3.4%), six cases of cerebrovascular disease (4.1%), and two cases of hydrocephalus (1.4%).
ConclusionIntellectual problems, ADHD, autism spectrum disorder, and migraine are major neurological comorbidities in NF1.

• 出版日期2018-1